Clin2
NCT04545242Possibly a fitRecruiting

Dexamethasone for severe lung failure from infections on ventilators

Acute Hypoxemic Respiratory Failure

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This trial studies whether dexamethasone (a steroid medicine) improves outcomes in adults who have sudden, severe breathing failure caused by an infection while they are on a breathing machine. It may help reduce inflammation in the lungs during critical illness.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
980 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are age 18 or older.
  • You are currently intubated and on a mechanical ventilator (a breathing machine).
  • Your breathing failure started recently and is severe (based on blood oxygen levels over a certain threshold for several hours).
  • Your breathing problem is being caused by a lung or whole-body infection.
  • You can take corticosteroids (or you do not have a known medical reason you cannot take them).

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07334379Recruiting· Phase 2
Tailored treatment for acute breathing problems

This trial tests whether using a blood test to measure inflammation (IL-6) can help doctors decide if you should get either dexamethasone or tocilizumab for COVID-19 or other acute breathing problems. The goal is to find the best treatment faster and reduce side effects.

Toronto, Ontario
NCT07576660Not yet recruiting· Phase 3
Dexamethasone for lung injury from sepsis

This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.

Nanjing, Jiangsu
NCT06496997Recruiting· Phase 2/Phase 3
Steroid treatment for acute lung failure (ARDS) trial

This study tests if adding a type of steroid (glucocorticoid) to standard treatment helps people on a breathing machine recover from severe lung failure (ARDS). It compares different doses to see which works best.

Al Fayyum
NCT06269900Recruiting· Phase 3
Dexamethasone for Severe Hospital-Acquired Pneumonia with Inflammation

This trial tests whether adding the anti-inflammatory drug dexamethasone to standard antibiotics improves recovery from severe hospital-acquired pneumonia in critically ill patients on a ventilator.

Amiens
NCT07199192Not yet recruiting· Phase 4
Steroid treatment for severe lung infections in hospitalized adults

This study tests whether giving steroids (a type of anti-inflammatory medicine) to adults hospitalized with severe respiratory infections can help them recover faster. If you have a serious lung infection and low oxygen levels, this trial may be an option for you.

Minneapolis, Minnesota
NCT06968559Recruiting· Phase 3
Early steroid treatment for severe burns

This study tests whether giving a steroid called dexamethasone early after a severe burn can reduce serious complications and the risk of death. It is for adults on a breathing machine with large burns.

Chambray-lès-Tours

Hear when a new Acute Hypoxemic Respiratory Failure trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.